Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
14
×
national blog main
startups
14
×
life sciences
biotech
boston blog main
boston top stories
national top stories
san francisco blog main
vc
new york blog main
wisconsin blog main
wisconsin top stories
boston
new york top stories
san diego blog main
fda
investing
san diego top stories
san francisco top stories
tech
wisconsin
cancer
clinical trials
glaxosmithkline
ipo
medical devices
raleigh-durham blog main
raleigh-durham top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cell therapy
crispr
cybersecurity
detroit blog main
detroit top stories
digital health
eli lilly
fintech
What
new
14
×
medicines
startup
biotech
cash
drug
drugs
medical
raises
therapeutics
wi
address
adds
based
bio
business
called
developing
device
disease
earlier
life
million
news
patients
public
roundup
tech
technology
today
venture
way
years
absorb
advance
ago
aiming
aims
alliance
allosteric
Language
unset
Current search:
startups
×
new
×
deals
×
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Boston Tech Watch: Polaris, GE, DataRobot, Facial Recognition Woes
@xconomy.com
4 years ago
WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
With New Cash and Facilities, Phoenix Transitions Out Of Startup Mode
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Under New Leaders, Name, PegEx Raises $8M for Waste Removal Software
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs